Clinical Trial Update: S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial of docetaxel and prednisone with or without atrasentan in metastatic prostate cancer with bone metastases after hormone therapy failure has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Prostate Cancer

Drugs mentioned

• Atrasentan (atrasentan)
• DOCETAXEL (DOCETAXEL)
• PREDNISONE (Prednisone)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Metastatic Cancer, Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-05-02